TCG Crossover Management, LLC 13F Holdings · Q2 2026
TCG Crossover Management, LLC reported 54 securities worth $4.16B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: ABVX (19.24%), TNGX (6.82%), CGON (6.27%). Among its top 25 positions this quarter: 3 new, 1 added, 5 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | $800.6M | 19.24% | 6.0M | Trimmed |
| 2 | TNGX | TANGO THERAPEUTICS INC | $283.9M | 6.82% | 9.1M | Trimmed |
| 3 | CGON | CG ONCOLOGY INC | $260.8M | 6.27% | 3.7M | Hold |
| 4 | COGT | COGENT BIOSCIENCES INC | $187.9M | 4.52% | 4.9M | Trimmed |
| 5 | IMVT | IMMUNOVANT INC | $171.8M | 4.13% | 4.5M | Hold |
| 6 | SYRE | SPYRE THERAPEUTICS INC | $168.7M | 4.06% | 1.9M | Hold |
| 7 | DNTH | DIANTHUS THERAPEUTICS INC | $163.4M | 3.93% | 1.7M | Hold |
| 8 | MIRM | MIRUM PHARMACEUTICALS INC | $124.3M | 2.99% | 1.1M | Hold |
| 9 | ZLAB | ZAI LAB LTD-ADR | $116.6M | 2.80% | 6.1M | New |
| 10 | AMLX | AMYLYX PHARMACEUTICALS INC | $112.1M | 2.70% | 6.2M | Hold |
| 11 | GLUE | MONTE ROSA THERAPEUTICS INC | $111.9M | 2.69% | 4.6M | Hold |
| 12 | BCRX | BIOCRYST PHARMACEUTICALS INC | $110.2M | 2.65% | 11.0M | Hold |
| 13 | VOR | VOR BIOPHARMA INC | $104.4M | 2.51% | 5.7M | Hold |
| 14 | TYRA | TYRA BIOSCIENCES INC | $103.8M | 2.49% | 3.2M | Hold |
| 15 | DYN | DYNE THERAPEUTICS INC | $102.5M | 2.46% | 4.6M | Hold |
| 16 | IRON | DISC MEDICINE INC | $98.1M | 2.36% | 1.3M | Hold |
| 17 | RLAY | RELAY THERAPEUTICS INC | $80.0M | 1.92% | 4.3M | Hold |
| 18 | SVRA | SAVARA INC | $76.2M | 1.83% | 12.4M | Hold |
| 19 | AURA | AURA BIOSCIENCES INC | $67.7M | 1.63% | 9.5M | New |
| 20 | RVMD | REVOLUTION MEDICINES INC | $63.8M | 1.53% | 340,899 | Trimmed |
| 21 | TRAX | FIRST TRACKS BIOTHERAPEUTICS | $58.3M | 1.40% | 2.9M | New |
| 22 | KOD | KODIAK SCIENCES INC | $56.3M | 1.35% | 1.4M | Hold |
| 23 | AVTX | AVALO THERAPEUTICS INC | $55.8M | 1.34% | 3.0M | Added |
| 24 | LBRX | LB PHARMACEUTICALS INC | $47.0M | 1.13% | 1.4M | Trimmed |
| 25 | IPSC | CENTURY THERAPEUTICS INC | $43.4M | 1.04% | 17.8M | Hold |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR